PHS
LLY icon

PFM Health Sciences’s Eli Lilly LLY Stock Holding History

PFM Health Sciences’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.1M Sell
39,258
-26,504
-40% -$27.1M 4.04% 3
2026
Q1 		$60.5M Sell
65,762
-2,527
-4% -$2.56M 5.52% 2
2025
Q4 		$73.4M Sell
68,289
-156,850
-70% -$150M 7.32% 2
2025
Q3 		$172M Sell
225,139
-42,884
-16% -$31.9M 13.21% 1
2025
Q2 		$209M Sell
268,023
-5,755
-2% -$4.47M 17.79% 1
2025
Q1 		$226M Sell
273,778
-24,865
-8% -$20.7M 16.42% 1
2024
Q4 		$231M Hold
298,643
– – 14.29% 1
2024
Q3 		$265M Hold
298,643
– – 14.99% 1
2024
Q2 		$270M Hold
298,643
– – 13.38% 1
2024
Q1 		$232M Hold
298,643
– – 10.92% 1
2023
Q4 		$174M Hold
298,643
– – 10.44% 1
2023
Q3 		$160M Hold
298,643
– – 7.56% 1
2023
Q2 		$140M Hold
298,643
– – 5.44% 1
2023
Q1 		$103M Hold
298,643
– – 4.53% 2
2022
Q4 		$109M Hold
298,643
– – 3.91% 3
2022
Q3 		$96.6M Hold
298,643
– – 3.49% 2
2022
Q2 		$96.8M Hold
298,643
– – 3.69% 3
2022
Q1 		$85.5M Hold
298,643
– – 3.2% 7
2021
Q4 		$82.5M Sell
298,643
-226,812
-43% -$57.5M 2.81% 8
2021
Q3 		$121M Hold
525,455
– – 3.57% 3
2021
Q2 		$121M Hold
525,455
– – 3.78% 4
2021
Q1 		$98.2M Buy
525,455
+174,810
+50% +$34.2M 3% 8
2020
Q4 		$59.2M Buy
+350,645
New +$52.4M 2.08% 10
2017
Q2 		– Sell
-575,249
Closed -$48.4M – 102
2017
Q1 		$48.4M Buy
+575,249
New +$46.1M 1.21% 30
2015
Q4 		– Sell
-1,106,139
Closed -$92.6M – 77
2015
Q3 		$92.6M Buy
+1,106,139
New +$93.4M 2.6% 12

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PFM Health Sciences's LLY Position: Q2 2026 in Review

PFM Health Sciences reduced its Eli Lilly (LLY) stake by 40% in Q2 2026, selling an estimated $27.1M and leaving 39,258 shares worth $47.1M. The position accounts for 4.04% of the portfolio, ranked #3.

PFM Health Sciences first reported a position in LLY in Q3 2015 and has held it in 25 quarters since. The position peaked at $270M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PFM Health Sciences held 39,258 shares of Eli Lilly worth $47.1M as of Q2 2026.
  • PFM Health Sciences sold 26,504 Eli Lilly shares in Q2 2026, an estimated $27.1M.
  • Eli Lilly made up 4.04% of PFM Health Sciences's portfolio in Q2 2026, its #3 holding.
  • PFM Health Sciences first reported a position in Eli Lilly in Q3 2015 and has held it in 25 quarters since.
  • PFM Health Sciences's Eli Lilly position peaked at $270M in Q2 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.